These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18347193)

  • 1. Sensitivity of squamous cell carcinoma lymph node metastases to herpes oncolytic therapy.
    Yu Z; Li S; Huang YY; Lin SF; Fong Y; Wong RJ
    Clin Cancer Res; 2008 Mar; 14(6):1897-904. PubMed ID: 18347193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity.
    Yu Z; Adusumilli PS; Eisenberg DP; Darr E; Ghossein RA; Li S; Liu S; Singh B; Shah JP; Fong Y; Wong RJ
    Mol Ther; 2007 Jan; 15(1):103-13. PubMed ID: 17164781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinoma.
    Yu Z; Li S; Huang YY; Fong Y; Wong RJ
    Cancer Gene Ther; 2007 Aug; 14(8):738-47. PubMed ID: 17525764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nectin-1 is a marker of thyroid cancer sensitivity to herpes oncolytic therapy.
    Huang YY; Yu Z; Lin SF; Li S; Fong Y; Wong RJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1965-70. PubMed ID: 17327376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases.
    Wong RJ; Joe JK; Kim SH; Shah JP; Horsburgh B; Fong Y
    Hum Gene Ther; 2002 Jul; 13(10):1213-23. PubMed ID: 12133274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced nectin-1 expression and herpes oncolytic sensitivity in highly migratory and invasive carcinoma.
    Yu Z; Chan MK; O-charoenrat P; Eisenberg DP; Shah JP; Singh B; Fong Y; Wong RJ
    Clin Cancer Res; 2005 Jul; 11(13):4889-97. PubMed ID: 16000587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma.
    Wong RJ; Patel SG; Kim S; DeMatteo RP; Malhotra S; Bennett JJ; St-Louis M; Shah JP; Johnson PA; Fong Y
    Hum Gene Ther; 2001 Feb; 12(3):253-65. PubMed ID: 11177562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus.
    Adusumilli PS; Eisenberg DP; Stiles BM; Chung S; Chan MK; Rusch VW; Fong Y
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1179-88. PubMed ID: 17059941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12.
    Wong RJ; Chan MK; Yu Z; Ghossein RA; Ngai I; Adusumilli PS; Stiles BM; Shah JP; Singh B; Fong Y
    Clin Cancer Res; 2004 Jul; 10(13):4509-16. PubMed ID: 15240543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
    Ikeda H; Uchida H; Okubo Y; Shibata T; Sasaki Y; Suzuki T; Hamada-Uematsu M; Hamasaki R; Okuda K; Yamaguchi M; Kojima M; Tanaka M; Hamada H; Tahara H
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33627393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.
    Varghese S; Rabkin SD; Liu R; Nielsen PG; Ipe T; Martuza RL
    Cancer Gene Ther; 2006 Mar; 13(3):253-65. PubMed ID: 16179929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
    Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.
    Shibata T; Uchida H; Shiroyama T; Okubo Y; Suzuki T; Ikeda H; Yamaguchi M; Miyagawa Y; Fukuhara T; Cohen JB; Glorioso JC; Watabe T; Hamada H; Tahara H
    Gene Ther; 2016 Jun; 23(6):479-88. PubMed ID: 26905369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma.
    Shin EJ; Wanna GB; Choi B; Aguila D; Ebert O; Genden EM; Woo SL
    Laryngoscope; 2007 Feb; 117(2):210-4. PubMed ID: 17204993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH; Wong RJ; Kooby DA; Carew JF; Adusumilli PS; Patel SG; Shah JP; Fong Y
    Eur J Cancer; 2005 Jan; 41(2):313-22. PubMed ID: 15661558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective intravenous therapy of murine pulmonary metastases with an oncolytic herpes virus expressing interleukin 12.
    Wong RJ; Chan MK; Yu Z; Kim TH; Bhargava A; Stiles BM; Horsburgh BC; Shah JP; Ghossein RA; Singh B; Fong Y
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):251-259. PubMed ID: 14734477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
    Varghese S; Rabkin SD; Nielsen GP; MacGarvey U; Liu R; Martuza RL
    Cancer Res; 2007 Oct; 67(19):9371-9. PubMed ID: 17909046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
    Wang J; Hu P; Zeng M; Rabkin SD; Liu R
    Int J Oncol; 2012 Mar; 40(3):757-63. PubMed ID: 22108767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1.
    Chen CH; Chen WY; Lin SF; Wong RJ
    Hum Gene Ther; 2014 Jun; 25(6):539-51. PubMed ID: 24568312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.